Infectious and Inflammatory Factors in Aetiology and Pathogenesis of Atherosclerosis;Infekční a Zánětlivé Faktory v Etiologii a Patogenezi Aterosklerózy

Vnitrni Lekarstvi

Volumn 49, Issue 12, 2003, Pages 960-966

  Anděl, Michael ^a,b   Tsevegjav, A ^a,b   Roubalova K ^c   Hruba D ^c   Dlouhy P ^d   Kraml, P ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Centrum Pro Diabetes a Vyzivu   (Czech Republic)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atherosclerosis; Infection; Pathogenesis; Prevention; Treatment

Indexed keywords

C REACTIVE PROTEIN; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN G ANTIBODY; AUTACOID;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNITY; CEREBROVASCULAR ACCIDENT; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM LESION; HEART INFARCTION; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS 1; HUMAN; INFECTION; INFLAMMATION; INFLUENZA VACCINATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PATHOGENESIS; ARTERIOSCLEROSIS; AUTOIMMUNE DISEASE; IMMUNOLOGY; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ARTERIOSCLEROSIS; AUTOIMMUNE DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; INFECTION; INFLAMMATION MEDIATORS;

EID: 1642553515     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Altannavch, T., Brož, J., Kraml, P.: Endotelium a infekce. DMEV 3, 2001, DMEV, 219-221
2. Altannavch, T., Roubalová, K., Brož, J. et al.: Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori in diabetic and non-diabetic patients with unstable angina pectoris. Centr. Europ. J. Pub. Health, 11, 2003, 102-106
3. Altannavch, T., Roubalová, K., Kučera, P. et al.: Effect of human cytomegalovirus and glucose on adhesion molecules expression in cultured human endothelial cells. Acta virologica, 43, 2002, 183-186
4. Altannavch, T., Roubalová, K., Kučera, P. et al.: Effect of high glucose on expression of adhesion molecules in HUVEC with and without cytokine stimulation. Physiol. Res., přijato do tisku, plánováno pro r. 2004.
5. Ameriso, S. F., Fridman, E. A., Leiguarda, R. C. et al.: Detection of Helicobacter Pylori in Human Carotis Atherosclerotic Plaques. Stroke, 32, 2001, 385-391
6. Anděl, M., Kraml, P., Dlouhý, P. et al.: Ateroskleróza. Od čistě metabolické choroby k chronickému zánětu s aspekty střádavé ho onemocnění. Prakt. Lék. 77, 1997, 265-275
7. Bláha, F.: Poznámky k patogeneze aterosklerózy ze zkušeností z koncentračního tábora. Čas. Lék. čes, 97, 1958, 85-89
8. Blankenberg, S., Rupprecht, H. J., Bickel, C. et al.: Cytomegalovirus infection with interleukin - 6 response predicts cardiac mortality in patients with coronary artery disease. Circulation 103, 2001 2915-2921
9. Brassard, P., Bourgault, C., Brophy, J. et al.: Antibiotics in Primary Prevention of Stroke in Elderly Stroke, 2003
10. Cleland, S. J., Sattar N., Petrie J. P. et al.: Endothelial dysfunction as a possible risk between C-reactive protein levels and cardiovascular disease. Clin. Sci. 98 (2000): 531-535
11. Espinola-Klein, C., Rupprecht, H.-J., Blankenberg, S. et al.: Impact of infection burden on progression of carotid atherosclerosis. Stroke, 33, 2002, 2581-2586
12. Espinola-Klein, C., Rupprecht, H.-J., Blankenberg, S. et al.: Impact of Infection Burden on Extent and Long-Term Prognosis of Atherosclerosis. Circulation, 105, 2002, 15-21
13. Esposito, K., Pontillo, A., Ciotola, M. et al.: Wight loss reduces interleukin-18 levels in obese women. J. Clin. Endocrinol. Metab. 8, 2002, 3864-3866
14. Fabricant, G. C., Fabricant, J., Litrenta, M. et al: Virus indiced atherosclerosis. J. Exp. Med. 148, 1978, 335-340
15. Fabricant, C. G., Hajjar, D. P., Minick, C. R. et al: Herpes infection enhances cholesterol and cholesteryl ester accumulation in arterial smooth muscle cells. Am. J. Pathol., 105, 1981, 176-184
16. Graham-Clarke, C., Chan, N., Andrew, D. et al.: Human Cytomegalovirus Seropositivity Is Associated With Impaired Vascular Function. Circulation 108, 2003, 678
17. Gurfinkel, E. P., de la Fuente, R. L., Mendiz, O. et al.: Influenza Vaccine Pilot Study in Acute Coronary Syndromes and Planned Percutaneous Coronary Interventions: The Flu Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation, 105, 2002, 2143
18. Hubáček, J. A., Poledne, R.: Infekce a ateroskleró za. Gramnegativní bakterie jako riziko aterosklerózy a infarktu myokardu. Prakticky̌ lékař 80, 2000, 246-248
19. Jara, L. J., Medina, G., Vera-Lastra, O. et al.: Atherosclerosis and antiphospholipid syndrome. Clin. Rev. Allergy Immunol. 2003, 25 (1): 79-88
20. Key, N. S., Vercelloti, G. M., Winkelmann, J. C. et al.: Infection of vascular endothelial cells with Herpes Simplex virus Enhances Tissue Factor Activity and Reduces Thrombomodulin Expression Proc. Natl. Acad. Sci. USA 87, 1990, 7095-7099
21. Kiechl S., Ether G., Mayer M.: Chronic Infections and the Risk of Carotid Atherosclerosis. Circulation. 2001; 103: 1064
22. Klotz, O., Manning, M.: Fatty streaks in intima of arteries. J. Pathol. Bacteriol., 16, 1912, 211-220
23. Krumholz, H. M.: Flu Vaccine for Cardiovascular Prevention in Elderly. J. Watch Cardiology, 9, 2003
24. Kuller, L. H., Tracey, R. P., Shaten, J. et al.: Relationship of C-reactive protein and coronary heart disease in MRFIT nested case control study. Am. J. Epidemiol. (1996) 144, 537-547
25. Lavallée, P., Perchaud, V. M., Gautier-Bertrand, M. et al.: Association between influenza vaccination and reduced risk of brain infarction. Stroke, 33, 2002, 513-518
26. Lindholt, J. S., Stovring, J., Andersen, P. L. et al.: A review of macrolide treatment of atherosclerosis and abdominal aortic anerysms. Curr. Drug Targets Infect. Disord. 3, 2003, 55-63
27. Liuba, P., Peterson, J., Luoma, J. et al.: Acute infections in children are accompanied by oxidative modification of LDL and decrease of HDL cholesterol, and are followed by thickening of carotid intima-media. Eur. Heart J., 24, 2003, 515-521
28. Mc Carthy: Interleukin-6 as central mediator of cardiovascular risk associated with chronic inflamation, smoking, diabetes and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxyphyline. Med. Hyotheses, 52, 1999, 465-477
29. Morré, S. A., Stooker, W., Lagrand, W. K. et al.: Microorganism in the etiology of atherosclerosis. J. Clin. Pathol., 53, 2000, 647-654
30. Naghavi, M., Wyde, P. Litovsky, S. et al.: Influenza infection exerts prominent inflamatory and thrombotis effects on atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation, 107, 2003, 762-768
31. Nichol, K. L., Nordin, J., Mulloly, J. et al.: Influenza Vaccination and Reduction in Hospitalization for Cardiac Disease and Stroke among the Elderly. N. Engl. J. Med., 348, 2003, 1322-1332
32. Osler, W.: Diseases of the arteries. In: Osler, W. (Ed): Modern medicine and its practice and theory. Lea and Febiger, Philadelphia, 1908, 429-447
33. Paterson, J. C., Cottral, G. E.: Experimental coronary sclerosis: lymphomatosis as a case of coronary sclerosis in chickens. Arch. Pathol 49, 1950, 699-709
34. Pilote, L., Green, L., Joseph, L. et al.: Antibiotics against Chlamydia pneumoniae and prognosis after acute myocardial infarction. Am. Heart J., 143, 2002, 294-300
35. Prasad, A., Zhu, J., Halcox, P. J. et al.: Predisposition to atherosclerosis by infection: role of endothelial dysfunction. Circulation, 106, 2002, 184-190
36. Pussinen, P. J., Jousilahti, P., Alfthan, G. et al.: Antibodies to Periodontal Pathogens are Associated with Coronary Heart Disease. Arterioscler. Thromb. Vasc. Biool. 23, 2003, 1250-1254
37. Reaven, G. M.: Role of insulin resistance in human disease. Banting lecture 1988. Diabetes, 37, 1988, 1595-1607
38. Ridker, P. M.: On evolutionary biology, inflamation, infection and causes of atherosclerosis. Circulation, 105, 2002, 2-4
39. Samulesson, L., Gottsater, A., Lindgrade, F.: Decreasing levels of tumor necrosis factor alpfa and interleukin-6 during lowering of body mass index with orlistat or placebo in obese subjects with cardiovascular risk factors. Diabetes Obes. Metab. 5, 2003, 195-201
40. Siscovick, D. S., Schwartz, S. M., Corey, L. et al.: Clamydia pneumoniae, Herpes Simplex Virus Type 1 and Cytomegalovirus and Incidence Myocardial Infarction and Coronary Heart Disease Death in Older Adults. The Cardiovascular Health Study. Circulation 102, 2000, 2335-2340
41. Staněk, V.: Ǔloha zánětu v etiologii aterosklerózy. Kapitoly z kardiologie 2, 2000, 1-5
42. Taylor-Robinson, D., Thomas, B. J., Goldin, H. et al.: Chlamydia pneumoniae in infrequently examined blood vessels. J. Clin. Pathol., 55, 2002, 218-220
43. Yung, B.: Influenza vaccination reduces risk of hospitalization for heart disease and CVD in subjects aged over 65 years. Thorax 58, 2003, 572
44. Zahn, R., Schneider, S., Frilling, B. et al. Working Group of Leading Hospital Cardiologists: Antibiotic therapy after acute myocardial infarction: a prospective randomized study. Circulation, 107, 2003, 1253-1259
45. Zhang, Y. X., Cliff, W. J., Shoefl, G. I. et al.: Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis 145 (1999), 375-379
46. Ziccardi, P., Nappo, F., Giugliano, G. et al.: Reduction of inflamatory cytokine concentrations and improvement of endothelial functions in obese women's after weight loss over one year. Circulation, 105, 2002, 804-809